The serotonin transporter knock-out rat: A review

Experimental Models in Serotonin Transporter Research

Volumn , Issue , 2010, Pages 170-213

  Olivier, Jocelien ^a   Cools, Alexander ^a   Ellenbroek, Bart ^b   Cuppen, Edwin ^c   Homberg, Judith ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c HUBRECHT INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952748643     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511729935.007     Document Type: Chapter

References (173)

1. Abel K, Waikar M, Pedro B, Hemsley D, Geyer M (1998). Repeated testing of prepulse inhibition and habituation of the startle reflex: a study in healthy human controls. J Psychopharmacol 12: 330-7.
2. Adamec R, Burton P, Blundell J, Murphy D L, Holmes A (2006). Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 170: 126-40.
3. Altamura C, Dell’Acqua M L, Moessner R, Murphy D L, Lesch K P, Persico A M (2007). Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb Cortex 17: 1394-401.
4. Ansorge M S, Zhou M, Lira A, Hen R, Gingrich J A (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-81.
5. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V (1976a). “Serotonin depression” - a biochemical subgroup within the affective disorders? Science 191: 478-80.
6. Asberg M, Traskman L, Thoren P (1976b). 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33: 1193-97.
7. Baker K E, Parker R (2004). Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr Opin Cell Biol 16: 293-9.
8. Bengel D, Murphy D L, Andrews A M, et al. (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice. Mol Pharmacol 53: 649-55.
9. Benmansour S, Cecchi M, Morilak D A, et al. (1999). Effects of chronic antidepressant treatments on serotonin transporter function, density and mRNA level. J Neuroscience 19: 10494-501.
10. Bentley A, MacLennan B, Calvo J, Dearolf C R (2000). Targeted recovery of mutations in Drosophila. Genetics 156: 1169-73.
11. Bill D J, Knight M, Forster E A, Fletcher A (1991). Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol 103: 1857-64.
12. Birrell J M, Brown V J (2000). Medial frontal cortex mediates perceptual attention set shifting in the rat. J Neurosci 20: 4320-4.
13. Blier P, de Montigny C, Chaput Y (1990). A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 51: 14-20.
14. Blier P, Seletti B, Gilbert F, Young S N, Benkelfat C (2002). Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation. Neuropsychopharmacology 27: 301-08.
15. Bolles R C, Woods P J (1964). The ontogeny of behavior in the albinorat. Anim Behav 12: 427-41.
16. Boulougouris V, Dalley J W, Robbins T W (2007). Effects of orbitofrontal, infralimbic, and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res 179: 219-28.
17. Bouwknecht J A, Hijzen T H, van der G J, Maes R A, Olivier B (2000). Stress-induced hyperthermia in mice: effects of flesinoxan on heart rate and body temperature. Eur J Pharmacol 400: 59-66.
18. Boyce-Rustay J M, Wiedholz L M, Millstein R A, et al. (2006). Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin Exp Res 30: 1957-65.
19. Braff D L, Geyer M A (1990). Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47: 181-8.
20. Briley M, Moret C (1993). Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 16: 387-400.
21. Cannon T D, Zorrilla L E, Shtasel D, et al. (1994). Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry 51: 651-61.
22. Capecchi M R (1989a). Altering the genome by homologous recombination. Science 244: 1288-92.
23. Capecchi M R (1989b). The new mouse genetics: altering the genome by gene targeting. Trends Genet 5: 70-6.
24. Carey RJ, DePalma G, Damianopoulos E, Muller C P, Huston J P (2004). The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior. Psychopharmacology 177: 46-54.
25. Carey R J, DePalma G, Damianopoulos E, Shanahan A, Muller C P, Huston J P (2005). Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res 1034: 162-71.
26. Carli M, Robbins T W, Evenden J L, Everitt B J (1983). Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction time task in rats - implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9: 361-80.
27. Carli M, Samanin R (1992). Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats’ performance differentially in a five-choice serial reaction time task. Psychopharmacology 106: 228-34.
28. Carlsson M, Carlsson A (1988). A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry 12: 53-61.
29. Carroll J C, Boyce-Rustay J M, Millstein R, et al. (2007). Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet 37: 214-22.
30. Carroll M E, Lac S T, Ascencio M, Kragh R (1990). Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35: 237-44.
31. Chon H, Gaillard C A, van der Meijden B B, et al. (2004). Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 43: 947-51.
32. Chudasama Y, Passetti F, Rhodes S E, Lopian D, Desai A, Robbins T W (2003). Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbito- frontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146: 105-19.
33. Clarke H F, Dalley J W, Crofts H S, Robbins T W, Roberts A C (2004). Cognitive inflexibility after prefrontal serotonin depletion. Science 304: 878-80.
34. Clarke H F, Walker S C, Crofts H S, Robbins T W, Roberts A C (2005). Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 12: 532-8.
35. Connor T J, Kelliher P, Shen Y, Harkin A, Kelly J P, Leonard B E (2000). Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacol Biochem Behav 65: 591-7.
36. Coppen A, Eccleston E, Craft I, Bye P (1973). Letter: Total and free plasma-tryptophan concentration and oral contraception. Lancet 2: 1498.
37. Cowen P J, Parry-Billings M, Newsholme E A (1989). Decreased plasma tryptophan levels in major depression. J Affect Disord 16: 27-31.
38. Cryan J F, Kelliher P, Kelly J P, Leonard B E (1999). Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635. J Psychopharmacol 13: 278-83.
39. Dalley J W, Cardinal R N, Robbins T W (2004). Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28: 771-84.
40. Dalley J W, Fryer T D, Brichard L, et al. (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-70.
41. Daws L C, Montanez S, Munn J L, et al. (2006). Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J Neurosci 26: 6431-8.
42. Dawson L A, Nguyen H Q, Smith D L, Schechter L E (2002). Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex. J Psychopharmacol 16: 145-52.
43. De Boer S F, Lesourd M, Mocaer E, Koolhaas J M (2000). Somatodendritic 5-HT1A autoreceptors mediate the antiaggressive actions of 5-HT1A receptor agonists in rats: an ethopharmacological study with S-15535, Alenspirone and WAY-100635. Neuropsychopharmacology 23: 20-33.
44. De Bruin J P C, Feenstra M G P, Broersen L M, et al. (2000). Role of the prefrontal cortex of the rat in learning and decision making: effects of transient inactivation. Prog Brain Res 126: 103-13.
45. de Jong T R, Pattij T, Veening J G, Waldinger M D, Cools A R, Olivier B (2005). Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT- induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. Psychopharmacology 179: 509-15.
46. de Visser L, van den Bos R, Kuurman W W, Kas M J, Spruijt B M (2006). Novel approach to the behavioral characterization of inbred mice: automated home cage observations. Genes Brain Behav 5: 458-66.
47. Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan M J (2000). The selective serotonin (5-HT)1A receptor ligand, S-15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely moving rats. A comparison with other anxiolytic agents. Psychopharmacology 152: 55-66.
48. Dominguez R, Cruz-Morales S E, Carvalho M C, Xavier M, Brandao M L (2003). Sex differences in serotonergic activity in dorsal and median raphe nucleus. Physiol Behav 80: 203-10.
49. Dragan W E, Oniszczenko W (2006). Association of a functional polymorphism in the serotonin transporter gene with personality traits in females in a Polish population. Neuropsychobiology 54: 45-50.
50. Drevets W C, Frank E, Price J C, et al. (1999). PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46: 1375-87.
51. Edwards D H, Kravitz E A (1997). Serotonin, social status and aggression. Curr Opin Neurobiol 7: 812-9.
52. Fabre V, Beaufour C, Evrard A, et al. (2000). Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12: 2299-310.
53. Fairbanks L A, Melega W P, Jorgensen M J, Kaplan J R, McGuire M T (2001). Social impulsivity inversely associated with CSF 5-HIAA and fluoxetine exposure in vervet monkeys. Neuropsychopharmacology 24: 370-8.
54. Ferrari P F, Palanza P, Parmigiani S, de Almeida R M, Miczek K A (2005). Serotonin and aggressive behavior in rodents and nonhuman primates: predispositions and plasticity. Eur J Pharmacol 526: 259-73.
55. Forcelli P A, Heinrichs S C (2007). Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring. Addict Biol 13: 52-62.
56. Fox M A, Andrews A M, Wendland J R, Lesch K P, Holmes A, Murphy D L (2007). A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology 195: 147-66.
57. Fuller R W (1996). The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology 14 (2): 77-81.
58. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F (2000). Neuroendocrine correlates of temperamental traits in humans. Psychoneuro- endorinology 25: 479-96.
59. Geyer M A, Krebs-Thomson K, Braff D L, Swerdlow N R (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenic patients: a decade in review. Psychopharmacology 156: 117-54.
60. Geyer M A, Tapson G S (1988). Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacology 1: 135-47.
61. Gibbs R A, Weinstock G M, Metzker M L, et al. (2004). Genome sequence of the Brown Norway rat yields insight into mammalian evolution. Nature 428:493-521.
62. Goodwin G M, De Souza R J, Green A R (1985). Presynaptic serotonin receptor- mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 317: 531-3.
63. Goodwin G M, De Souza R J, Green A R, Heal D J (1987). The pharmacology of the behavioral and hypothermic responses of rats to 8-hydroxy-2-(di-n-propyl- amino)tetralin (8-OH-DPAT). Psychopharmacology 91: 506-11.
64. Gorman J M (2006). Gender differences in depression and response to psychotropic medication. Gend Med 3: 93-109.
65. Griffith R R, Bigelow G E, Henningfield J E (1980). Similarities in animal and human drug-taking behavior. In Mello NK, editor. Advances in substance abuse Vol. 1. Greenwich, CT: JAI Press, pp. 1-90.
66. Haberstick B C, Smolen A, Hewitt J K (2006). Family-based association test of the 5HTTLPR and aggressive behavior in a general population sample of children. Biol Psychiatry 59: 36-43.
67. Haleem D J, Kennett G A, Curzon G (1990). Hippocampal 5-hydroxytryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT1A agonist 8-OH-DPAT. J Neural Transm Gen Sect 79: 93-101.
68. Harison A A, Everitt B J, Robbins T W (1997). Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergiz mechanisms. Psychopharmacology 133: 329-42.
69. Heikkila R E, Orlansky H, Cohen G (1975). Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24: 847-52.
70. Heinz A, Jones D W, Mazzanti C, et al. (2000). A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47: 643-9.
71. Higley J D, Linnoila M (1997). Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior. A nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann NY Acad Sci USA 836: 39-56.
72. Higgins G A, Bradbury A J, Jones B J, Oakley N R (1988). Behavioral and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology 27: 993-1001.
73. Hillegaart V (1991). Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on core temperature in the rat. Psychopharmacology 103: 291-6.
74. Hodos W (1961). Progressive ratio as a measure of reward strength. Science 134: 943-4.
75. Hogg S (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54: 21-30.
76. Hol T, Van den Berg C, Van Ree J M, Spruijt B M (1999). Isolation during the play period in infancy decreases adult social interactions in rats. Behav Brain Res 100: 91-7.
77. Holmes A, Li Q, Murphy D L, Gold E, Crawley J N (2003a). Abnormal anxiety- related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2: 365-80.
78. Holmes A, Murphy D L, Crawley J N (2002a). Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology 161: 160-7.
79. Holmes A, Murphy D L, Crawley J N (2003b). Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 54: 953-9.
80. Holmes A, Yang RJ, Murphy D L, Crawley J N (2002b). Evaluation of antidepressant- related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27: 914-23.
81. Homberg J R, Arends B, Wardeh G, Raaso H S, Schoffelmeer A N M, De Vries T J (2004). Individual differences in the effects of serotonergic anxiolytic drugs on the motivation to self-administer cocaine. Neuroscience 128: 121-30.
82. Homberg J R, Braam B, Ellenbroek B, Cuppen E, Joles J A (2006). Blood pressure in mutant rats lacking the 5-hydroxytryptamine (5-HT) transporter. Hypertension 48: e115-6.
83. Homberg J R, Olivier J D A, Smits B M G, et al. (2007a). Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146: 1662-76.
84. Homberg J R, Pattij T, Janssen M C W, et al. (2007c). Serotonin transporter deficiency in rats improves inhibitory control but not behavioral flexibility. Eur J Neurosci 26: 2066-73.
85. Homberg J R, Schiepers O J G, Schoffelmeer A N M, Cuppen E, Vanderschuren L J M J (2007b). Acute and constitutive increases in central serotonin levels reduce social play behavior in periadolescent rats. Psychopharmacology 195: 175-82.
86. Jans L A, Riedel W J, Markus C R, Blokland A (2007). Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12: 522-43.
87. Jansen G, Hazendonk E, Thijssen K L, Plasterk R H (1997). Reverse genetics by chemical mutagenesis in Caenorhabditis elegans. Nat Genet 17: 119-21.
88. Kalueff A V, Fox M A, Gallagher P S, Murphy D L (2007a). Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 6: 389-400.
89. Kalueff AV, Gallagher P S, Murphy D L (2006). Are serotonin transporter knockout mice ‘depressed’?: hypoactivity but no anhedonia. Neuroreport 17: 1347-51.
90. Kalueff A V, Jensen C L, Murphy D L (2007b). Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Res 1169: 87-97.
91. Kelal S, Aissi F, Lesch K P, Cohen-Salmon C, Hamon M, Lanfumey L (2003). Alcohol intake after serotonin transporter inactivation in mice. Alcohol Alcohol 38:386-9.
92. Kim D K, Tolliver T J, Huang S J, et al. (2005). Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49: 798-810.
93. Koob G F (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177-84.
94. Kranzler H, Lappalainen J, Nellissery M, Gelernter J (2002). Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene. Alcohol Clin Exp Res 26: 1330-5.
95. Larson E T, Summers C H (2001). Serotonin reverses dominant social status. Behav Brain Res 121: 95-102.
96. Lauder J M (1990). Ontogeny of the serotonin system in the rat: serotonin as a developmental signal. Ann NY Acad Sci 600: 297-313.
97. Leibowitz S F, Alexander J T (1998). Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44: 851-64.
98. LeMarquand D, Pihl R O, Benkelfat C (1994). Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 36: 395-421.
99. Linnoila M, Virkkunen M, Scheinin M, Nuutile A, Rimon R, Goodwin F K (1983). Low cerebrospinal-fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 33: 2609-14.
100. Lira A, Zhou M, Castanon N, et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter- deficient mice. Biol Psychiatry 54: 960-71.
101. Mann J J, Huang Y Y, Underwood M D, et al. (2000). A serotonin transporter gene promoter polymorphism. (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57: 729-38.
102. Masaki D, Yokoyama C, Kinoshita S, et al. (2006). Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats. Psychopharmacology 189: 249-58.
103. Maurel S, De Vry J, Schreiber R (1999). Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvox- amine in alcohol-preferring cAA rats. Alcohol 17: 195-201.
104. Martin K F, Phillips I, Hearson M, Prow M R, Heal D J (1992). Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br J Pharmacol 107: 15-21.
105. Mathews T A, Fedele D E, Coppelli F M, Avila A M, Murphy D L, Andrews A M (2004). Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 140: 169-81.
106. McBride W J, Murphy J M, Gatto G J, et al. (1993). CNS mechanisms of alcohol administration. Alcohol Alcohol 2: 463-7.
107. McCallum C M, Comai L, Greene E A, Henikoff S (2000). Targeted screening for induced mutations. Nat Biotechnol 18: 455-7.
108. Millan M J, Rivet J M, Canton H, et al. (1993a). S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively. Eur J Pharmacol 230: 99-102.
109. Millan M J, Rivet J M, Canton H, le Marmouille-Girardon S, Gobert A (1993b). Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor- mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. J Pharmacol Exp Ther 264: 1364-76.
110. Montanez S, Owens W A, Gould G G, Murphy D L, Daws L C (2003). Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem 86: 210-9.
111. Muir J L, Everitt B J, Robbins T W (1996). The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6: 470-81.
112. Murphy F C, Smith K A, Cowen P J, Robbins T W, Sahakian B J (2002). The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology 163: 42-53.
113. Muscat R, Papp M, Willner P (1992). Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology 109: 433-8.
114. Myers D P, Renaut S D, Collier M J (2004). The Morris maze as a test of learning and memory in rats - a case study demonstrating the value of re-testing the same set of animals. Toxicology 202: 132-3.
115. Naranjo C A, Kadlec K E, Sanhueza P, Woodley-Remus D, Sellers E M (1990). Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 47: 490-8.
116. New A S, Buchsbaum M S, Hazlett E A, et al. (2004). Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology 176: 451-8.
117. Newman-Tancredi A, Rivet J, Chaput C, Touzard M, Verriele L, Millan M J (1999). The 5HT(1A) receptor ligand, S-15535, antagonises G-protein activation: a [35S] GTPgammaS and [3H]S-15535 autoradiography study. Eur J Pharmacol 384: 111-21.
118. Ni W, Lookingland K, Watts S W (2006). Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and N{omega}-nitro- L-arginine but not spontaneously hypertensive rats. Hypertension 48: 134-40.
119. Nishizawa S, Benkelfat C, Young S N, et al. (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 94: 5308-13.
120. Olivier B (2004). Serotonin and aggression. Ann NY Acad Sci 1036: 382-92.
121. Olivier B, Chan J S, Pattij T, et al. (2006). Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Int J Impot Res 18 (suppl. 1): S14-23.
122. Olivier J D A, van der Hart M G C, van Swelm R P L, et al. (2008). A study in male and female serotonin transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152: 573-84.
123. Olivier B, Zethof T J, Ronken E, van der Heyden J A (1998). Anxiolytic effects of flesinoxan in the stress-induced hyperthermia paradigm in singly-housed mice are 5-HT1A receptor mediated. Eur J Pharmacol 342: 177-82.
124. Owens M J, Nemeroff C B (1998). The serotonin transporter and depression. Depression Anxiety 8: 5-12.
125. Paine T A, Jackman S L, Olmstead M C (2002). Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol 13: 511-23.
126. Passetti F, Dalley J W, Robbins T W, (2003). Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five- choice reaction time task. Psychopharmacology 165: 136-45.
127. Pellis S M, Pasztor T J (1999). The developmental onset of a rudimentary form of play fighting in C57 mice. Dev Psychobiol 34: 175-82.
128. Peltier R, Schenk S (1993). Effects of serotonergic manipulations on cocaine selfadministration in rats. Psychopharmacology 110: 390-4.
129. Perry J A, Wang T L, Welham T J, et al. (2003). A TILLING reverse genetics tool and a web-accessible collection of mutants of the legume Lotus japonicus. Plant Physiol 131: 866-71.
130. Persico A M, Mengual E, Moessner R, et al. (2001). Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 21: 6862-73.
131. Pierce R C, Kumaresan V (2006). The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30: 215-38.
132. Poole T B, Fish J (1975). An investigation of playful behavior in Rattus norvegicus and Mus musculus (Mammalia). J Zool 175: 61-71.
133. Popova L K (2006). From genes to aggressive behavior: the role of serotonergic system. Bioessays 28: 495-503.
134. Prickaerts J, Raaijmakers W, Blokland A (1996). Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat. Physiol Behav 60: 43-50.
135. Prut L, Belzung C (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33.
136. Reith M E, Sershen H, Lajtha A (1980). Saturable [3H]cocaine binding in central nervous system of mouse. Life Sci 27: 1055-62.
137. Richardson N R, Roberts DCS (1996). Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine selfadministration in the rat. Life Sci 49: 833-840.
138. Robbins T W (2005). Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493: 140-6.
139. Rogers R D, Blackshaw A J, Middleton H C, et al. (1999). Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monaminergic basis of impulsive behavior. Psychopharmacology 146: 482-91.
140. Rogers D C, Fisher E M, Brown S D, Peters J, Hunter A J, Martin J E (1997). Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8: 711-3.
141. Salichon N, Caspar P, Upton A L (2001). Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-HT transporter knock-out mice. J Neurosci 21: 884-96.
142. Sargent P A, Kjaer K H, Bench C J, et al. (2000). Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57: 174-80.
143. Saykin A J, Shtasel D, Cur R E, et al. (1994). Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 51: 124-31.
144. Seibell P J, Demarest J, Rhoads D E (2003). 5-HT1A receptor activity disrupts spontaneous alternation behavior in rats. Pharmacol Biochem Behav 74: 559-64.
145. Serretti A, Mandelli L, Lorenzi C, et al. (2006). Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms. Neuropsychobiology 53: 9-16.
146. Shen H W, Hagino Y, Kobayashi H, et al. (2004). Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29: 1790-9.
147. Shephard R A, Broadhurst P L (1982). Hyponeophagia and arousal in rats: effects of diazepam, 5-methoxy-N, N-dimethyltryptamine, D-amphetamine and food deprivation. Psychopharmacology 78: 368-72.
148. Simpson K L, Fisher T M, Waterhouse B D, Lin R C (1998). Projection patterns from the raphe nuclear complex to the ependymal wall of the ventricular system in the rat. J Comp Neurol 399: 61-72.
149. Smits B M C, Cuppen E (2005). Rat genetics: the next episode. Trends Genetics 22: 232-40.
150. Smits B M C, Mudde J, Plasterk R H A, Cuppen E (2004). Target-selected mutagenesis of the rat. Genomics 83: 332-4.
151. Smits B M, Mudde J B, van de Belt J, et al. (2006). Ceneration of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis. Pharmacogenet Genomics 16: 159-69.
152. Sora I, Hall F S, Andrews A M, et al. (2001). Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98: 5300-05.
153. Sora I, Wichems C, Takahashi N, et al. (1998). Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin- transporter knockout mice. Proc Natl Acad Sci USA 13: 7699-704.
154. Taravosh-Lahn K, Bastida C, Delville Y (2006). Differential responsiveness to fluoxetine during puberty. Behav Neurosci 120: 1084-92.
155. Till B J, Reynolds S H, Weil C, et al. (2004). Discovery of induced point mutations in maize genes by TILLING. BMC Plant Biol 28: 4-12.
156. Van den Berg C L, Hol T, Van Ree J M, Spruijt B M, Everts H, Koolhaas J M (1999). Play is indispensable for an adequate development of coping with social challenges in the rat. Dev Psychobiol 34: 129-38.
157. Vanderschuren L J M J, Niesink R J M, van Ree J M (1997). The neurobiology of social play behavior in rats. Neurosci Biobehav Rev 21: 309-26.
158. Vizi E S, Zsilla C, Caron M C, Kiss J P (2004). Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J Neurosci 24: 7888-94.
159. Walsh S L, Cunningham K A (1997). Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology 130: 41-58.
160. Watts S W (2005). 5-HT in systemic hypertension: foe, friend or fantasy? Clin Sci (Lond.) 108: 399-412. Review. PMID: 15831089.
161. Watts A G, Stanley H F (1984). Indoleamines in the hypothalamus and area of the midbrain raphe nuclei of male and female rats throughout postnatal development. Neuroendocrinology 38: 461-6.
162. Wellman C L, Izquierdo A, Garrett J E, et al. (2007). Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 27: 684-91.
163. Whitaker-Azmitia P M (2005). Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci 23: 75-83.
164. Wichems C H, Andrews A M, Heils A, Li Q, Lesch K P, Murphy D L (1998). Spontaneous behavior differences and altered responses to psychomotor stimulants in mice lacking the serotonin transporter. 28th Annual Meeting of the Society for Neuroscience.
165. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93: 358-64.
166. Winstanley C A, Chadusama Y, Dalley J W, Theobald D E, Glennon J C, Robbins T W (2003). Intra-prefrontal 8-OHDPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology 167: 304-14.
167. Winstanley C A, Dalley J W, Theobald D E, Robbins T W (2004). Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 7: 1331-43.
168. Winstanley C A, Eagle D M, Robbins T W (2006). Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 26: 379-95.
169. Wise R A (2002). Brain reward circuitry: insights from unsensed incentives. Neuron 36: 229-40.
170. Yamada J, Sugimoto Y, Horisaka K (1988). The behavioral effects of 8-hydroxy-2-(di- N-propylamino)tetralin (8-OH-DPAT) in mice. Eur J Pharmacol 154: 299-304.
171. Zan Y, Haag J D, Chen K S, et al. (2003). Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat Biotech 21: 645-51.
172. Zhao S, Edwards J, Carroll J, et al. (2006). Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion- related behaviors in mice. Neuroscience 140: 321-34.
173. Zhou F C, Lesch K P, Murphy D L (2002). Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942: 109-19.